Open access
Aug 2026
OA08.2. Impact of GLP1 Receptor Agonists on Progression of Non Dysplastic Barrett’s Esophagus: A Large Propensity Matched Cohort Study
GLP-1 therapy was associated with an increased risk of progression to dysplastic BE/EC in patients with non-dysplastic BE, and further prospective studies are warranted to validate these results.
Russaal S. Mann, K. Sachdeva, L. Dhaliwal et al.
· Diseases of the esophagus · 0 citations